ROYAL BANK OF CANADA - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 36 filers reported holding ETON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$17,000
+1600.0%
4,881
+1219.2%
0.00%
Q1 2023$1,000370
+655.1%
0.00%
Q3 2022$049
+113.0%
0.00%
Q1 2022$0
-100.0%
23
-97.7%
0.00%
Q3 2021$5,000
-73.7%
1,000
-67.9%
0.00%
Q2 2021$19,000
-95.7%
3,113
-94.8%
0.00%
Q1 2021$443,000
-9.2%
60,421
+0.6%
0.00%
Q4 2020$488,000
+4.1%
60,087
+1.4%
0.00%
Q3 2020$469,000
+43.0%
59,259
-1.6%
0.00%
Q2 2020$328,000
+22.4%
60,247
-7.7%
0.00%
Q1 2020$268,000
-42.0%
65,249
+1.6%
0.00%
Q4 2019$462,000
+6500.0%
64,217
+5706.2%
0.00%
Q3 2019$7,0001,1060.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders